Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 5.80
-0.06 (-1.02%)
Sep 15, 2026, 5:35 PM CET
Carvolix Market Cap
Carvolix has a market cap or net worth of €347.17 million as of September 15, 2026. Its market cap has increased by 458.41% in one year.
Market Cap
347.17M
Enterprise Value
365.24M
Revenue
900.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.80
ChartMarket Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 347.17M, an increase of 138.91%. That is a compound annual growth rate of 18.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 347.17M | 410.00% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 204.39M |
| Median Technologies | 146.93M |
| Guerbet | 93.98M |
| Theraclion | 47.67M |
| Novacyt | 36.69M |
| Mauna Kea Technologies | 29.54M |
| Diagnostic Medical Systems | 25.19M |
| Implanet | 24.42M |